Ultrastructural and immunohistochemical contribution to the histogenesis of human cardiac myxoma.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 3363683)

Published in Ultrastruct Pathol on June 02, 1988

Authors

E Govoni1, B Severi, G Cenacchi, R Laschi, S Pileri, M T Rivano, G Alampi, A Branzi

Author Affiliations

1: Institute of Clinical Electron Microscopy, University of Bologna, Italy.

Articles by these authors

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15

Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12

Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med (1995) 4.51

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood (2000) 3.99

A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood (2000) 3.13

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A (1991) 2.82

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med (1997) 2.59

ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41

Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40

ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38

Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol (1982) 2.22

Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group. Lancet (1995) 2.05

Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03

Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol (1989) 1.89

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81

BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76

Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66

MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol (2009) 1.62

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation (1994) 1.61

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia (2009) 1.56

Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51

Medullocytoma (lipidized medulloblastoma). A cerebellar neoplasm of adults with favorable prognosis. Am J Surg Pathol (1996) 1.44

[Ultrastructural lesions produced in hepatic parenchymal cells by phalloidin and alpha-amanitin]. Sperimentale (1966) 1.43

Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol (1993) 1.43

Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42

Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up. Cathet Cardiovasc Diagn (1997) 1.40

Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. Hum Pathol (2004) 1.39

Epithelioid leiomyoma of the breast with granular cell change: a case report. Hum Pathol (1993) 1.38

Human cytomegalovirus structural components: intracellular and intraviral localization of p28 and p65-69 by immunoelectron microscopy. Virus Res (1987) 1.38

Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood (1995) 1.37

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia (2007) 1.36

Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35

Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34

Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment Pharmacol Ther (2003) 1.33

Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leuk Res (1989) 1.31

Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol (1996) 1.30

Lipomatous meningioma: a clinicopathologic study of 18 cases with special reference to the issue of metaplasia. Am J Surg Pathol (2001) 1.30

Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes). Histopathology (1990) 1.24

Histological and immunohistological analysis of human lymphomas. Crit Rev Oncol Hematol (1989) 1.22

Basement membrane production by hepatocytes in chronic liver disease. Hepatology (1985) 1.21

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Ann Oncol (2009) 1.20

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. Ann Oncol (2006) 1.16

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. Ann Oncol (2008) 1.14

Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. Hum Pathol (1990) 1.13

Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12

Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood (1997) 1.12

Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol (1996) 1.11

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol (1993) 1.10

Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology (2001) 1.08

A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol (1995) 1.07

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07

Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Clin Exp Immunol (1987) 1.06

A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06

Giant cell tumor of bone: a model for the in vitro human osteoclast characterization. Tumori (1989) 1.05

Tumor cell growth fraction in Hodgkin's disease. Am J Pathol (1987) 1.05

An unusual marrow transplant complication: cardiac myxoma. Bone Marrow Transplant (1998) 1.04

Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04

Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (1987) 1.04

Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol (1997) 1.03

Pulmonary arterial hypertension associated to connective tissue diseases. Lupus (2005) 1.03

Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res (1994) 1.02

B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol (1998) 1.00

Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.00

Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood (1996) 1.00

Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. Blood (2001) 0.99

Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies. Histopathology (1987) 0.99

Mixed tumors, myoepitheliomas, and oncocytomas of the soft tissues are likely members of the same family: a clinicopathologic and ultrastructural study. Ultrastruct Pathol (2001) 0.99

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther (1998) 0.99

A new acrylic resin formulation: a useful tool for histological, ultrastructural, and immunocytochemical investigations. J Histochem Cytochem (1992) 0.99

Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol (1997) 0.99

Benefits in projected pacemaker longevity and in pacing related costs conferred by automatic threshold tracking. Pacing Clin Electrophysiol (2000) 0.99

Histiocytic necrotizing lymphadenitis without granulocytic infiltration (Kikuchi's lymphadenitis). Morphological and immunohistochemical study of eight cases. Histopathology (1987) 0.98

Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features. Acta Haematol (1984) 0.98

Evaluation of the pulse-contour method of determining stroke volume in man. Circulation (1972) 0.98

Expression of the CD30 antigen in non-lymphoid tissues and cells. J Pathol (2000) 0.97

Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol (1996) 0.97

Endodermal sinus tumor arising in the endometrium. Obstet Gynecol (1980) 0.97

Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol (2001) 0.96

Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol (1990) 0.96

Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatry (1994) 0.96

[Extramedullary plasmocytoma (EMP) of the head and neck: a series of 22 cases]. Acta Otorhinolaryngol Ital (1995) 0.95

Immunohistological characterization of lymph nodes in two cases of adult onset Still's disease. J Rheumatol (1991) 0.94

Detection of mucus glycoconjugates in human conjunctiva by using the lectin-colloidal gold technique in TEM. II. A quantitative study in dry-eye patients. Acta Ophthalmol (Copenh) (1986) 0.94

Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart (2008) 0.93

Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. Leukemia (2011) 0.92

Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol (1995) 0.92

Malignant tumors in patients with human immunodeficiency virus infection: a report of 580 cases. J Clin Oncol (1989) 0.92

Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery. Heart (2006) 0.92

Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol (1998) 0.91

Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol (2008) 0.91

Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol (1997) 0.91

Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-concept. Curr Cancer Drug Targets (2010) 0.91

Human cytomegalovirus nuclear and cytoplasmic dense bodies. Arch Virol (1992) 0.91

Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91